Theravance Biopharma
(NASDAQ:TBPH)
$9.73
0.67[7.40%]
At close: Jul 1
$9.50
-0.2300[-2.36%]
After Hours: 4:06PM EDT
Day High/Low9.1 - 9.97
52 Week High/Low6.1 - 15.01
Open / Close9.12 / 9.73
Float / Outstanding49.4M / 76.1M
Vol / Avg.777.7K / 525.3K
Mkt Cap740.6M
P/E-
50d Avg. Price9.14
Div / Yield-
Payout Ratio-
EPS-0.34
Total Float49.4M

Theravance Biopharma (NASDAQ:TBPH), Quotes and News Summary

Theravance Biopharma (NASDAQ: TBPH)

Day High/Low9.1 - 9.97
52 Week High/Low6.1 - 15.01
Open / Close9.12 / 9.73
Float / Outstanding49.4M / 76.1M
Vol / Avg.777.7K / 525.3K
Mkt Cap740.6M
P/E-
50d Avg. Price9.14
Div / Yield-
Payout Ratio-
EPS-0.34
Total Float49.4M
load more
Sector: Health Care.Industry: Pharmaceuticals
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS-0.110-0.220 -0.1100
REV14.480M13.196M-1.284M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Theravance Biopharma Questions & Answers

Q
How do I buy Theravance Biopharma (TBPH) stock?
A

You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Theravance Biopharma's (TBPH) competitors?
Q
What is the target price for Theravance Biopharma (TBPH) stock?
A

The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by SVB Leerink on Monday, May 23, 2022. The analyst firm set a price target for 12.00 expecting TBPH to rise to within 12 months (a possible 23.33% upside). 14 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Theravance Biopharma (TBPH)?
A

The stock price for Theravance Biopharma (NASDAQ: TBPH) is $9.73 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Theravance Biopharma (TBPH) pay a dividend?
A

There are no upcoming dividends for Theravance Biopharma.

Q
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
A

Theravance Biopharma’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is Theravance Biopharma (TBPH) going to split?
A

There is no upcoming split for Theravance Biopharma.

Q
What sector and industry does Theravance Biopharma (TBPH) operate in?
A

Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.